Envisu C2300 is the first OCT system to be cleared by the FDA for handheld imaging, and for imaging of patients from premature infants to adult, seated or supine, awake or under anesthesia. These products are also cleared for use in the European Union, Canada, and Australia.
For Pre-Clinical Research
Whether the aim is to improve productivity in translational research or reduce costs associated with pre-clinical discovery and development, the Bioptigen Envisu R-Class systems are designed to provide pre-clinical researchers with the best in high throughput, high resolution imaging systems. These systems are suitable for rapid screening and in-depth analysis with unparalleled image quality and maximum flexibility for wide dynamic range images of animal models including mice, rabbits, zebrafish and more.